These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26656463)

  • 1. Alcohol consumption and mortality in patients with mild Alzheimer's disease: a prospective cohort study.
    Berntsen S; Kragstrup J; Siersma V; Waldemar G; Waldorff FB
    BMJ Open; 2015 Dec; 5(12):e007851. PubMed ID: 26656463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor self-rated health did not increase risk of permanent nursing placement or mortality in people with mild Alzheimer's disease.
    Nielsen AB; Siersma V; Waldemar G; Waldorff FB
    BMC Geriatr; 2016 Apr; 16():87. PubMed ID: 27094158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of psychosocial intervention in patients with mild Alzheimer's disease: the multicentre, rater blinded, randomised Danish Alzheimer Intervention Study (DAISY).
    Waldorff FB; Buss DV; Eckermann A; Rasmussen ML; Keiding N; Rishøj S; Siersma V; Sørensen J; Sørensen LV; Vogel A; Waldemar G
    BMJ; 2012 Jul; 345():e4693. PubMed ID: 22807076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Mini-Mental State Examination score in Alzheimer's disease patients after stopping habitual drinking.
    Toda A; Tagata Y; Nakada T; Komatsu M; Shibata N; Arai H
    Psychogeriatrics; 2013 Jun; 13(2):94-8. PubMed ID: 23909966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-year follow-up on the efficacy of psychosocial interventions for patients with mild dementia and their caregivers: the multicentre, rater-blinded, randomised Danish Alzheimer Intervention Study (DAISY).
    Phung KT; Waldorff FB; Buss DV; Eckermann A; Keiding N; Rishøj S; Siersma V; Sørensen J; Søgaard R; Sørensen LV; Vogel A; Waldemar G
    BMJ Open; 2013 Nov; 3(11):e003584. PubMed ID: 24270834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
    Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
    Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
    Wattmo C; Minthon L; Wallin ÅK
    Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Alcohol Use and the Progression of Alzheimer's Disease.
    Heymann D; Stern Y; Cosentino S; Tatarina-Nulman O; Dorrejo JN; Gu Y
    Curr Alzheimer Res; 2016; 13(12):1356-1362. PubMed ID: 27628432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol consumption and risk of unemployment, sickness absence and disability pension in Denmark: a prospective cohort study.
    Jørgensen MB; Thygesen LC; Becker U; Tolstrup JS
    Addiction; 2017 Oct; 112(10):1754-1764. PubMed ID: 28544338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-rated health in patients with mild Alzheimer's disease: baseline data from the Danish Alzheimer Intervention Study.
    Waldorff FB; Nielsen AB; Waldemar G
    Arch Gerontol Geriatr; 2010; 50(1):1-5. PubMed ID: 19181399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancy between self- and proxy-rated pain in Alzheimer's disease: results from the Danish Alzheimer Intervention Study.
    Jensen-Dahm C; Vogel A; Waldorff FB; Waldemar G
    J Am Geriatr Soc; 2012 Jul; 60(7):1274-8. PubMed ID: 22702408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Antipsychotics on Secular Mortality Trends in Patients With Alzheimer's Disease.
    Nielsen RE; Valentin JB; Lolk A; Andersen K
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29659206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of an abnormal one-leg balance in community-dwelling patients with Alzheimer's disease: a 2-year prospective study in 686 patients of the REAL.FR study.
    Sourdet S; van Kan GA; Soto ME; Houles M; Cantet C; Nourhashemi F; Vellas B; Pahor M; Rolland Y
    J Am Med Dir Assoc; 2012 May; 13(4):407.e1-6. PubMed ID: 22227074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study.
    Hager K; Baseman AS; Nye JS; Brashear HR; Han J; Sano M; Davis B; Richards HM
    Alzheimers Res Ther; 2016 Nov; 8(1):47. PubMed ID: 27846868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of transition from mild cognitive impairment to Alzheimer's disease and death: A cohort study.
    Xue H; Sun Q; Liu L; Zhou L; Liang R; He R; Yu H
    Compr Psychiatry; 2017 Oct; 78():91-97. PubMed ID: 28806610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol drinking patterns and risk of diabetes: a cohort study of 70,551 men and women from the general Danish population.
    Holst C; Becker U; Jørgensen ME; Grønbæk M; Tolstrup JS
    Diabetologia; 2017 Oct; 60(10):1941-1950. PubMed ID: 28748324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.
    Orgogozo JM; Dartigues JF; Lafont S; Letenneur L; Commenges D; Salamon R; Renaud S; Breteler MB
    Rev Neurol (Paris); 1997 Apr; 153(3):185-92. PubMed ID: 9296132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
    Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.